Richard Grove

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis

Per Soelberg Sørensen, Steen Lisby, Richard Grove et al. · Neurology · 2014 · 276 citations

Pharmacy, Neurology, Pharmacotherapy +17

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis

Amit Bar‐Or, Richard Grove, Daren Austin et al. · Neurology · 2018 · 214 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

K. Hewett, Donald B. Sanders, Richard Grove et al. · Neurology · 2018 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study

Caryl Schwartzbach, Richard Grove, Robert A. Brown et al. · Journal of Neurology · 2016 · 113 citations · Full text

Medicine, Neurology, Pharmacology +15

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17